Pharmaceutical News

RSS

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

"The cost of immunizing children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group," Reuters reports.

19 Apr 2013

Blog examines implications of synthetic artemisinin production for global health

"This week, PATH and our partners celebrated the official launch of the production line for a new synthetic version of artemisinin, the key ingredient for the gold-standard malaria treatment -- one that plays a major role in protecting the lives of children and adults worldwide," PATH President and CEO Steve Davis writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

19 Apr 2013

Global experts highlight strategies to immunize more children

In advance of World Immunization Week, global experts are highlighting strategies to further advance progress on the Global Vaccine Action Plan that was endorsed by the World Health Assembly, 2012.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

Dietary supplements accounted for more than half the Class 1 drugs recalled by the U.S. Food and Drug Administration from 2004-12, meaning they contained substances that could cause serious health problems or even death, a new study from St. Michael's Hospital has found.

19 Apr 2013

Antibiotic resistance: A growing problem in hospital and outpatient settings

A new study concludes that problems with antibiotic resistance faced by outpatients may be as bad as those in hospitalized patients, and that more studies of outpatients are needed - both to protect their health and to avoid inappropriate or unnecessary drug use.

19 Apr 2013

First Edition: April 18, 2013

Today's headlines include reports from Capitol Hill about one Democratic senator's poor reviews of the Obama administration's progress in implementing the health law.

18 Apr 2013

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid Drug Platform.

18 Apr 2013

Amgen agrees to $25M settlement after kickback allegations

The biotech drug maker was accused of paying kickbacks to increase sales of its anemia drug Aranesp.

18 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

A new study concludes that approximately half of the prescriptions of Tamiflu during the 2009-10 influenza pandemic went unused in England.

18 Apr 2013

Study confirms crizotinib drug reduces testosterone levels

A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib.

17 Apr 2013

Santarus, Pharming Group submit Biologics License Application to FDA for RUCONEST

Santarus, Inc. and Pharming Group NV today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration to obtain marketing approval for RUCONEST (recombinant human C1 esterase inhibitor) 50 U/kg, an investigational drug for the treatment of acute angioedema attacks in patients with hereditary angioedema.

17 Apr 2013

University of Alberta researcher develops polymer platform technology for targeted drug delivery

A University of Alberta researcher is thinking small to find innovative ways to improve the delivery of drugs that can be more easily administered with fewer side-effects.

17 Apr 2013

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

Studies have shown that about 10 percent of men infected with human immunodeficiency virus have an elevated resting energy expenditure.

17 Apr 2013

Acetaminophen may help reduce existential pain

Thinking about death can cause us to feel a sort of existential angst that isn't attributable to a specific source. Now, new research suggests that acetaminophen, an over-the-counter pain medication, may help to reduce this existential pain.

17 Apr 2013

Viewpoints: 9 'brilliant legal minds' wrestle with tough biological questions in gene case; Drug overdoses take surprising toll in Calif.; VA case raises privacy questions

When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes cuts both ways, leading to a potential split among the justices (Jon Healey, 4/15).

17 Apr 2013

FDA issues Complete Response Letter to Allergan's NDA for LEVADEX

Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.

17 Apr 2013

Pharmaceutical News

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

Blog examines implications of synthetic artemisinin production for global health

Global experts highlight strategies to immunize more children

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

Antibiotic resistance: A growing problem in hospital and outpatient settings

First Edition: April 18, 2013

New review of medications to prevent migraines appears in Journal of General Internal Medicine

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Amgen agrees to $25M settlement after kickback allegations

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Study confirms crizotinib drug reduces testosterone levels

Santarus, Pharming Group submit Biologics License Application to FDA for RUCONEST

University of Alberta researcher develops polymer platform technology for targeted drug delivery

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

Acetaminophen may help reduce existential pain

Viewpoints: 9 'brilliant legal minds' wrestle with tough biological questions in gene case; Drug overdoses take surprising toll in Calif.; VA case raises privacy questions

FDA issues Complete Response Letter to Allergan's NDA for LEVADEX

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News